Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Miscellaneous

This is a Phase 1 open-label, multicenter study of the safety and tolerability, immunogenic effects, antitumor activity, and pharmacodynamics of SQZ-PBMC-HPV as monotherapy and in combination with atezolizumab in HLA-A*02+ patients with recurrent, locally advanced or metastatic human papillomavirus strain 16 positive (HPV16+) solid tumors. The study includes patients with anal, rectal, cervical, head and neck, penile, vulvar, or vaginal cancer.
Miscellaneous
I
Eng, Cathy
NCT04084951
VICCGIP1990

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: